These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34082967)

  • 1. Shear stress and ROS-responsive biomimetic micelles for atherosclerosis via ROS consumption.
    Shen M; Li H; Yao S; Wu X; Liu S; Yang Q; Zhang Y; Du J; Qi S; Li Y
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112164. PubMed ID: 34082967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shear Stress and ROS Dual-Responsive RBC-Hitchhiking Nanoparticles for Atherosclerosis Therapy.
    Shen M; Jiang H; Zhao Y; Wu L; Yang H; Yao Y; Meng H; Yang Q; Liu L; Li Y
    ACS Appl Mater Interfaces; 2023 Sep; 15(37):43374-43386. PubMed ID: 37669139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ROS and shear stress dual-sensitive bionic system with cross-linked dendrimers for atherosclerosis therapy.
    Shen M; Yao S; Li S; Wu X; Liu S; Yang Q; Du J; Wang J; Zheng X; Li Y
    Nanoscale; 2021 Dec; 13(47):20013-20027. PubMed ID: 34842887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.
    Wu T; Chen X; Wang Y; Xiao H; Peng Y; Lin L; Xia W; Long M; Tao J; Shuai X
    Nanomedicine; 2018 Oct; 14(7):2215-2226. PubMed ID: 29964220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ROS-responsive multifunctional targeted prodrug micelle for atherosclerosis treatment.
    Zhou Z; Liu Y; Xie P; Yin Z
    Int J Pharm; 2024 Jul; 660():124352. PubMed ID: 38901540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis.
    Mu D; Li J; Qi Y; Sun X; Liu Y; Shen S; Li Y; Xu B; Zhang B
    J Nanobiotechnology; 2020 Dec; 18(1):179. PubMed ID: 33287831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.
    Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation.
    Luo X; Zhang M; Dai W; Xiao X; Li X; Zhu Y; Shi X; Li Z
    J Nanobiotechnology; 2024 Jul; 22(1):440. PubMed ID: 39061065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis.
    Hou X; Lin H; Zhou X; Cheng Z; Li Y; Liu X; Zhao F; Zhu Y; Zhang P; Chen D
    Carbohydr Polym; 2020 Mar; 232():115787. PubMed ID: 31952595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS Responsive Nanoplatform with Two-Photon AIE Imaging for Atherosclerosis Diagnosis and "Two-Pronged" Therapy.
    Ma B; Xu H; Zhuang W; Wang Y; Li G; Wang Y
    Small; 2020 Nov; 16(45):e2003253. PubMed ID: 33078569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.
    Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H
    J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA-Loaded Micelles Functionalized with Rosmarinic Acid: A Novel Synergistic Anti-Inflammatory Strategy for Treatment of Atherosclerosis.
    Liu M; Liu S; Zhu X; Sun Y; Su L; Yu H; Liu D; Li Y; Du Y; Liu R; Sun K
    J Pharm Sci; 2022 Oct; 111(10):2827-2838. PubMed ID: 35580692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment.
    Zhao R; Ning X; Wang M; Wang H; Xing G; Wang L; Lu C; Yu A; Wang Y
    ACS Appl Mater Interfaces; 2022 Jun; 14(22):25080-25092. PubMed ID: 35618653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in biomimetic nanomedicines based on versatile targeting strategy for atherosclerosis therapy.
    Liang L; Deng Y; Ao Z; Liao C; Tian J; Li C; Yu X
    J Drug Target; 2024 Jul; 32(6):606-623. PubMed ID: 38656224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-modality probe nanodrug delivery systems with ROS-sensitivity for atherosclerosis diagnosis and therapy.
    Shen M; Jiang H; Li S; Liu L; Yang Q; Yang H; Zhao Y; Meng H; Wang J; Li Y
    J Mater Chem B; 2024 Jan; 12(5):1344-1354. PubMed ID: 38230621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
    Dai L; Yu Y; Luo Z; Li M; Chen W; Shen X; Chen F; Sun Q; Zhang Q; Gu H; Cai K
    Biomaterials; 2016 Oct; 104():1-17. PubMed ID: 27423095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor efficacy of hybrid micelles with mitochondrial targeting and stimuli-responsive drug release behavior.
    Chen Z; Zhang Z; Chen M; Xie S; Wang T; Li X
    J Mater Chem B; 2019 Mar; 7(9):1415-1426. PubMed ID: 32255012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound responsive self-assembled micelles loaded with hypocrellin for cancer sonodynamic therapy.
    Liu X; Zhao K; Cao J; Qi X; Wu L; Shen S
    Int J Pharm; 2021 Oct; 608():121052. PubMed ID: 34500056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic dual cell therapy for atherosclerosis regression: ROS-responsive Bio-liposomes co-loaded with Geniposide and Emodin.
    Li Z; Zhu H; Liu H; Liu D; Liu J; Zhang Y; Qin Z; Xu Y; Peng Y; Ruan L; Li J; He Y; Liu B; Long Y
    J Nanobiotechnology; 2024 Mar; 22(1):129. PubMed ID: 38528554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.